May 27, 2009 – A single high dose of radiotherapy is as effective in relieving the pain from vertebral bone metastases as 10 smaller treatments according to new research from the Radiation Therapy Oncology Group (RTOG) that will be presented at the American Society of Clinical Oncology Annual Meeting in Orlando on May 31, 2009. RTOG, an NCI-funded national clinical trials group, is a clinical research component of the American College of Radiology (ACR).

RTOG researchers previously reported that breast and prostate cancer patients with painful bone metastases who received a single radiotherapy treatment of 8 Gy had the same pain relief and narcotic use three months after treatment as patients who received 10 radiotherapy treatments each consisting of 2 Gy for a total of 30 Gy. Researchers also found that patients who received the 8 Gy regimen reported in fewer side effects, although those patients did have to be retreated more often than patients who received the higher dose.

In order to evaluate the effectiveness of short course radiotherapy in patients with painful vertebral bone metastases the RTOG investigators examined a 235 patient subset of the 909 patients entered on the original study, RTOG 9714. The RTOG researchers found the short course to be equally effective as the longer course (8 Gy vs. 30 Gy) showing no statistically significant difference in pain relief [70 percent vs. 62 percent, p=0.59] or narcotic use [27 percent vs. 24 percent, p=0.76] at 3 months.

“It is exciting to confirm that we can provide the same amount of pain relief for patients suffering with vertebral bone metastases with only one visit to their radiation oncologist as we have been providing with 10 visits,” said David D Howell, M.D., the lead author of the analysis from the University of Michigan School of Medicine in Ann Arbor. “With fewer side-effects and comparable pain relief, the single dose treatment is very much appreciated, especially for patients who have already completed one or more courses of treatment for their primary disease.”

For more information: www.acr.org


Related Content

News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
Subscribe Now